Understanding Different Types of Glaucoma: Comprehensive Guide to Symptoms, Diagnosis, and Treatment Options

 Key Takeaways

• Glaucoma is the leading cause of irreversible blindness in the United States among people of African descent, and second globally, but up to 50% of cases go undiagnosed.

• Primary open-angle glaucoma (POAG) accounts for roughly 75% of all glaucoma cases in the U.S.

• Normal-tension glaucoma damages the optic nerve even when eye pressure is normal, making it particularly easy to miss.

• Risk increases sharply after age 60, and African American and Hispanic populations face at least a threefold higher prevalence than non-Latino white populations.

• There is no cure, but with early detection and consistent treatment, vision loss can be slowed or stopped.

• Regular eye exams at River Town Eye Care in Hastings, MN are the single most reliable way to catch glaucoma before permanent damage occurs.

  
  

What is glaucoma, and why does it matter so much?

Glaucoma isn't one disease; it's a group of optic nerve disorders that, left untreated, steal vision permanently. The optic nerve carries visual signals from the eye to the brain. When it deteriorates, those signals get lost, and so does sight.

What makes glaucoma especially dangerous is how quietly it moves. Most people don't notice anything wrong until a significant portion of their peripheral vision is already gone. A 2023 review in American Family Physician estimated that up to 50% of people living with glaucoma don't know they have it, and that number climbs even higher in medically underserved populations.

Globally, researchers project the number of people affected will grow from roughly 60 million today to 112 million by 2040. In the United States alone, cases are expected to double from 3 million to 6 million by 2050. Those numbers aren't abstract; they reflect people in communities like Hastings, Dakota County, and the surrounding Twin Cities metro who may be losing vision right now without knowing why.

What are the main types of glaucoma?

Primary open-angle glaucoma (POAG)

Primary open-angle glaucoma is the most common form of glaucoma, accounting for approximately 75% of all glaucoma cases in the U.S., according to a 2023 clinical review published in American Family Physician. In POAG, the eye's drainage canals gradually clog over time, raising intraocular pressure (IOP), the fluid pressure inside the eye. That pressure slowly presses on and damages the optic nerve.

The problem is that this happens without pain and without noticeable vision changes until the disease is already advanced. A 2021 meta-analysis in Scientific Reports (Zhang et al.) reviewed 50 population-based studies covering nearly 200,000 people and confirmed that age, African or Hispanic ethnicity, and family history are the most consistent risk factors for POAG. People of African descent face at least a threefold higher risk than non-Latino white populations, a disparity that researchers believe involves both biological and socioeconomic access factors.

One particularly sobering statistic from the American Family Physician review: approximately 10% of people with elevated IOP develop glaucoma within five years, and 30% do so within 20 years. Yet roughly 40% of people with confirmed glaucoma have normal IOP at their first diagnosis, which means pressure alone can't rule out the disease.

Glaucoma can present itself in several ways.

Angle-closure glaucoma: the one that strikes fast

Primary angle-closure glaucoma (PACG) happens when the iris physically blocks the eye's drainage angle, causing IOP to spike rapidly. Unlike POAG, this form can produce sudden, dramatic symptoms: severe eye pain, headaches, nausea, blurred vision, and colored halos around lights. Acute angle closure is a medical emergency that requires immediate treatment.

A 2021 meta-analysis in Frontiers in Medicine (Zhang et al.) analyzed 37 population-based studies involving over 144,000 subjects and found PACG is far more prevalent in Asian populations, accounting for more than 75% of the global PACG population. That same study confirmed that PACG risk increases with age, and women face higher rates than men.

A separate 2022 meta-analysis published in Eye found that PACG carries a disproportionately high risk of bilateral blindness compared to POAG — meaning both eyes are more likely to be affected. That makes early identification of anatomically narrow drainage angles critically important, even before symptoms develop.

Normal-tension glaucoma: the one that breaks the rules

Normal-tension glaucoma (NTG) is one of the most misunderstood forms of the disease. The optic nerve deteriorates just like it does in POAG, with characteristic cupping, retinal nerve fiber layer thinning, and visual field loss, but IOP stays within the statistically normal range (below 21 mmHg). There is no pressure spike to trigger alarm.

Research published in NCBI Bookshelf (StatPearls) describes NTG as likely a heterogeneous, multifactorial condition. Proposed mechanisms include vascular insufficiency at the optic nerve head, oxidative stress, metabolic dysfunction, and structural weakness of the lamina cribrosa, the connective tissue through which optic nerve fibers pass. Genetics also plays a role, with three known Mendelian gene associations identified in NTG patients.

The vascular hypothesis is currently one of the strongest areas of investigation. A 2022 study in the Journal of Glaucoma (Funk et al., PMID: 34731871) found that multiple systemic vascular conditions, including Raynaud syndrome, migraine headaches, peripheral vascular disease, and anemia, were independently associated with NTG. These conditions may reduce blood perfusion to the optic nerve, leading to retinal ganglion cell death through a pressure-independent pathway.

The landmark Collaborative Normal Tension Glaucoma Study found that reducing IOP by 30% slowed disease progression, even when that pressure was already normal, confirming that pressure does play some role, even in NTG.

Congenital glaucoma: rare but serious

Congenital glaucoma occurs in infants and young children due to abnormal development of the eye's drainage system before birth. It's rare, but early detection is critical. Warning signs in infants include cloudy corneas, excessive tearing, sensitivity to light, and enlarged-looking eyes. When caught early, surgical intervention can preserve vision.

Who is most at risk for developing glaucoma?

Risk factors backed by medical research

Age is the most consistent predictor across all glaucoma types. The American Family Physician review estimated a 3.5% prevalence of glaucoma in adults over 40, rising sharply with each decade.

Family history matters significantly. Having a first-degree relative with glaucoma increases personal risk substantially. For NTG specifically, the StatPearls review notes a strong family history association and ethnic variation in prevalence that persists even after migration — suggesting a genetic component beyond shared environment.

Ethnicity shapes risk in ways researchers are still trying to fully understand. People of African descent face the highest rates of POAG in the U.S. — at least three times higher than non-Latino white populations — and also carry the highest rates of glaucoma-related blindness. Hispanic populations face similarly elevated risk. Asian populations, meanwhile, account for a disproportionate share of angle-closure glaucoma cases worldwide.

Beyond demographics, several systemic health conditions raise glaucoma risk. The American Family Physician 2023 review specifically identified type 2 diabetes, hypotension, hypothyroidism, obstructive sleep apnea (OSA), cardiovascular disease, and myopia as established POAG risk factors. OSA has also emerged as a risk factor for NTG, specifically repetitive nighttime hypoxia from airway obstruction, which may impair blood flow to the optic nerve.

How do eye doctors actually diagnose glaucoma?

The tests used at a comprehensive eye exam

Glaucoma can't be diagnosed with a single measurement; it requires a combination of tests evaluated over time. Here's what a thorough eye exam for glaucoma screening involves.

Tonometry measures IOP. The most common method is the "air puff" or applanation tonometry. While pressure above 21 mmHg raises concern, remember that up to 40% of confirmed glaucoma cases present with normal IOP, so tonometry alone is never sufficient.

Ophthalmoscopy lets the doctor examine the optic nerve directly, looking for characteristic cupping (enlargement of the optic disc's central cup), disc hemorrhages, and asymmetry between the two eyes.

Optical coherence tomography (OCT) produces detailed imaging of the retinal nerve fiber layer and optic nerve head. The American Family Physician review identified a cup-to-disc ratio of 0.3 or greater and nerve fiber layer defects on OCT as two of the primary diagnostic criteria for POAG.

Visual field testing assesses peripheral vision to detect the blind spots and scotomas that glaucoma characteristically creates. Because visual field loss in POAG is gradual and initially occurs in the periphery, patients often don't notice it until the damage is significant, which is exactly why testing matters before symptoms appear.

Gonioscopy examines the drainage angle of the eye directly and helps differentiate POAG from angle-closure variants. It's particularly important for patients with anatomically shallow anterior chambers who may be at risk for PACG.

The American Family Physician review noted that diagnosing POAG "often requires monitoring over years to document changes", reinforcing why consistent, long-term follow-up with the same eye care provider matters.

What treatment options are available for glaucoma?

Medications, lasers, and surgery: each with a role

No treatment reverses glaucoma damage that has already occurred. The goal is to stop or slow further progression. IOP reduction remains the only proven, modifiable intervention across all glaucoma types.

Prescription eye drops are the standard first-line treatment. Prostaglandin analogs (like latanoprost) are typically the most effective single agents for lowering IOP and are usually prescribed once daily. Beta-blockers, alpha agonists, and carbonic anhydrase inhibitors offer additional options or can be combined when one medication isn't sufficient.

For NTG specifically, the StatPearls review notes that magnesium, calcium channel blockers, and carbonic anhydrase inhibitors may improve ocular blood flow regulation in addition to lowering IOP, addressing the vascular component of the disease.

Laser trabeculoplasty (selective laser trabeculoplasty, or SLT) uses a low-energy laser to improve drainage through the trabecular meshwork. Clinical evidence supports SLT as an effective alternative or adjunct to eye drops for POAG, with some patients maintaining IOP control for years after a single treatment.

Surgical options include trabeculectomy, which creates a new drainage channel, and micro-invasive glaucoma surgery (MIGS) procedures, which offer lower-risk alternatives for mild to moderate disease. Drainage device implantation is used in more advanced or refractory cases.

For acute angle-closure attacks, laser peripheral iridotomy, which creates a small hole in the iris to restore drainage, is the emergency and preventive treatment of choice.

Treatment adherence matters enormously. Eye drops only work when used consistently, and research shows medication non-adherence is one of the most common reasons glaucoma progresses despite treatment.

How can people in Minnesota protect their vision from glaucoma?

What you can actually do right now.

The most protective action is the most straightforward: get a comprehensive eye exam. The American Family Physician recommends exams every one to two years for adults over 40 who carry risk factors, more frequently for those with elevated IOP, a family history of glaucoma, or a previous diagnosis.

Beyond exams, several lifestyle factors influence glaucoma risk. Regular aerobic exercise has been shown in multiple studies to modestly lower IOP and may improve ocular blood flow. A diet that includes leafy greens and foods rich in omega-3 fatty acids supports vascular health. Managing systemic conditions like diabetes, hypertension, and sleep apnea reduces IOP fluctuation and protects optic nerve perfusion.

For patients already on glaucoma medications, consistent drop adherence is the single most controllable variable in disease management. Setting a phone reminder, tying drops to a daily routine like brushing teeth, and keeping medications visible all help.

Early detection is the most powerful tool against glaucoma. It starts with an annual eye exam.

Rivertown Eye Care in Hastings, MN offers comprehensive glaucoma screening and ongoing management for patients across the Dakota County area. If you have risk factors (particularly age over 60, a family history, or African or Hispanic ancestry), scheduling a dilated eye exam is the most direct step you can take to protect your vision before damage begins.

Frequently Asked Questions

What lifestyle changes can help reduce the risk of developing glaucoma?

Making certain lifestyle changes can significantly lower the risk of developing glaucoma. Regular physical activity, such as aerobic exercises, can help maintain healthy intraocular pressure. A balanced diet rich in fruits, vegetables, and omega-3 fatty acids supports overall eye health. Additionally, managing chronic conditions like diabetes and hypertension is crucial. Avoiding smoking and limiting alcohol consumption can also contribute to better eye health. Regular eye exams are essential for early detection, especially for those at higher risk.

Are there any specific eye exercises that can help with glaucoma?

While there are no specific eye exercises proven to prevent or treat glaucoma, maintaining overall eye health through regular eye movement and relaxation techniques can be beneficial. Practices such as palming, focusing on distant objects, and gentle eye rotations may help reduce eye strain. However, these exercises should not replace medical treatment or regular check-ups. It's essential to follow your eye care professional's advice regarding glaucoma management and treatment options.

How often should individuals at risk for glaucoma have eye exams?

Individuals at risk for glaucoma, such as those over 60 or with a family history of the disease, should have comprehensive eye exams at least every one to two years. Those with existing risk factors, such as high intraocular pressure or other eye conditions, may need more frequent evaluations. Early detection is crucial for effective management, so adhering to a regular eye exam schedule is vital for monitoring eye health and preventing vision loss.

Can glaucoma be hereditary, and should family members be screened?

Yes, glaucoma can be hereditary, and having a family history of the disease significantly increases an individual's risk. If a family member has been diagnosed with glaucoma, it is advisable for other family members to undergo regular eye screenings. Early detection through screening can lead to timely intervention and management, which is essential for preserving vision. Discussing family history with an eye care professional can help determine the appropriate screening schedule.

What are the potential side effects of glaucoma medications?

Glaucoma medications, particularly eye drops, can have side effects, although they vary by medication type. Common side effects may include eye irritation, redness, blurred vision, and a change in eyelash growth. Some systemic side effects, such as fatigue or changes in heart rate, can occur with certain oral medications. It's important for patients to discuss any side effects with their eye care provider, as adjustments to the treatment plan may be necessary to ensure effective intraocular pressure management.

Is there a cure for glaucoma, or is it a lifelong condition?

Currently, there is no cure for glaucoma; it is generally considered a lifelong condition. However, with proper management, including medications, laser treatments, or surgery, individuals can control intraocular pressure and prevent further vision loss. Regular follow-ups with an eye care professional are essential to monitor the condition and adjust treatment as needed. Early detection and adherence to treatment plans can significantly improve outcomes for those living with glaucoma.

---

Sources

1. Gupta D, Chen PP. Glaucoma: Diagnosis and Management. Am Fam Physician. 2023;107(3):253-262. https://www.aafp.org/pubs/afp/issues/2023/0300/glaucoma.html

2. Zhang N, Wang J, Li Y, Jiang B. Prevalence of primary open angle glaucoma in the last 20 years: a meta-analysis and systematic review. Sci Rep. 2021;11(1):13762. https://doi.org/10.1038/s41598-021-92971-w

3. Zhang N, Wang J, Chen B, Li Y, Jiang B. Prevalence of Primary Angle Closure Glaucoma in the Last 20 Years: A Meta-Analysis and Systematic Review. Front Med. 2021;7:624179. https://doi.org/10.3389/fmed.2020.624179

4. Ramulu P, et al. Blindness in glaucoma: primary open-angle glaucoma versus primary angle-closure glaucoma — a meta-analysis. Eye (Lond). 2022;36(11):2099-2105. https://doi.org/10.1038/s41433-021-01802-9

5. Funk RO, Hodge DO, Kohli D, Roddy GW. Multiple Systemic Vascular Risk Factors Are Associated With Low-Tension Glaucoma. J Glaucoma. 2022;31(1):15-22. https://doi.org/10.1097/IJG.0000000000001964

6. Nguyen CT, et al. Normal Tension Glaucoma. In: StatPearls [Internet]. Treasure Island, FL: StatPearls Publishing; 2022. https://www.ncbi.nlm.nih.gov/books/NBK576377/

7. Schuster AK, et al. Open-Angle Glaucoma: Risk Factors & Screening. Dtsch Arztebl Int. 2020;117(31-32):532-541. https://doi.org/10.3238/arztebl.2020.0532

8. Flammer J, et al. New insights in the pathogenesis and treatment of normal tension glaucoma. Curr Opin Pharmacol. 2013;13(1):43-9. https://pubmed.ncbi.nlm.nih.gov/23092679/